Lee, Richel E.

HRN: 26-81-47  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2025
CEFUROXIME 1.5GM (VIAL)
08/04/2025
08/11/2025
IVTT
1.5g
1 Hr Prior To OR Then Q8 Thereafter
Cholecystolithiasis Not In Cholecystitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: